Compensatory fronto-parietal hyperactivation during set-shifting in unmedicated patients with Parkinson's disease

Neuropsychologia

Volumn 68, Issue , 2015, Pages 107-116

  Gerrits, Niels J H M ^a,c   van der Werf, Ysbrand D ^a,b,c   Verhoef, Kim M W ^a   Veltman, Dick J ^a,c   Groenewegen, Henk J ^a,c   Berendse, Henk W ^a,c   van den Heuvel, Odile A ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c Department of Neurology VUmc ^*  (Netherlands)

Author keywords

Cognition; Compensation; Functional MRI; Parkinson's disease; Set shifting

Indexed keywords

DOPAMINE TRANSPORTER;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEEDBACK SYSTEM; FEMALE; FRONTAL OPERCULUM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; INSULA; LEFT HANDEDNESS; MALE; NERVE CELL STIMULATION; PARIETAL CORTEX; PARKINSON DISEASE; PREFRONTAL CORTEX; PROTEIN BINDING; RIGHT HANDEDNESS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STIMULUS RESPONSE; SUPERIOR FRONTAL GYRUS; TASK PERFORMANCE; VENTROMEDIAL PREFRONTAL CORTEX; EXECUTIVE FUNCTION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE;

ADULT; AGED; EXECUTIVE FUNCTION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARIETAL LOBE; PARKINSON DISEASE; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE;

EID: 84921061619     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2014.12.022     Document Type: Article

References (45)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989, 12(10):366-375.
2. Au W.L., Zhou J., Palmes P., Sitoh Y.Y., Tan L.C., Rajapakse J.C. Levodopa and the feedback process on set-shifting in Parkinson's disease. Hum. Brain Mapp. 2012, 33(1):27-39.
3. Beck A.T., Epstein N., Brown G., Steer R.A. An inventory for measuring clinical anxiety: psychometric properties. J. Consult. Clin. Psychol. 1988, 56(6):893-897.
4. Beck A.T., Steer R.A., Ball R., Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J. Personal. Assess. 1996, 67(3):588-597.
5. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24(2):197-211.
6. Brittain J.S., Brown P. Oscillations and the basal ganglia: motor control and beyond. NeuroImage 2013, 85(Pt 2):637-647.
7. Buchsbaum B.R., Greer S., Chang W.L., Berman K.F. Meta-analysis of neuroimaging studies of the Wisconsin card-sorting task and component processes. Hum. Brain Mapp. 2005, 25(1):35-45.
8. Chaudhuri K.R., Healy D.G., Schapira A.H. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006, 5(3):235-245.
9. Chaudhuri K.R., Schapira A.H. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009, 8(5):464-474.
10. Cockrell J.R., Folstein M.F. Mini-Mental State Examination (MMSE). Psychopharmacol. Bull. 1988, 24(4):689-692.
11. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci. Biobehav. Rev. 2006, 30(1):1-23.
12. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb. Cortex 2001, 11(12):1136-1143.
13. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. Mechanisms of cognitive set flexibility in Parkinson's disease. Brain 2001, 124(Pt 12):2503-2512.
14. Daniel S.E., Lees A.J. Parkinson's Disease Society Brain Bank, London: overview and research. J. Neural. Transm. Suppl. 1993, 39:165-172.
15. Downes J.J., Roberts A.C., Sahakian B.J., Evenden J.L., Morris R.G., Robbins T.W. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia 1989, 27(11-12):1329-1343.
16. Fahn S., Elton R.L., Committee M.O.T.U.D. Unified Parkinson's disease rating scale. Recent Developments in Parkinson's Disease 1987, 153-164. Macmillan Healthcare Information, Florham Park, NJ. S. Fahn, C.D. Marsden, D. Calne, M. Goldstein (Eds.).
17. Frank M.J., Seeberger L.C., O'Reilly R.C. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 2004, 306(5703):1940-1943.
18. Grahn J.A., Parkinson J.A., Owen A.M. The role of the basal ganglia in learning and memory: neuropsychological studies. Behav. Brain Res. 2009, 199(1):53-60.
19. Grant D.A., Berg E.A. A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem. J. Exp. Psychol. 1948, 38(4):404-411.
20. Greicius M.D., Menon V. Default-mode activity during a passive sensory task: uncoupled from deactivation but impacting activation. J. Cogn. Neurosci. 2004, 16(9):1484-1492.
21. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17(5):427-442.
22. Jokinen P., Karrasch M., Bruck A., Johansson J., Bergman J., Rinne J.O. Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction. J. Neurol. Sci. 2013, 329(1-2):23-28.
23. Kehagia A.A., Barker R.A., Robbins T.W. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol 2010, 9(12):1200-1213.
24. Kim C., Cilles S.E., Johnson N.F., Gold B.T. Domain general and domain preferential brain regions associated with different types of task switching: a meta-analysis. Hum. Brain Mapp. 2012, 33(1):130-142.
25. Lees A.J., Hardy J., Revesz T. Parkinson's disease. Lancet 2009, 373(9680):2055-2066.
26. Monchi O., Ko J.H., Strafella A.P. Striatal dopamine release during performance of executive functions: a [(11)C] raclopride PET study. NeuroImage 2006, 33(3):907-912.
27. Monchi O., Petrides M., Doyon J., Postuma R.B., Worsley K., Dagher A. Neural bases of set-shifting deficits in Parkinson's disease. J. Neurosci. 2004, 24(3):702-710.
28. Monchi O., Petrides M., Mejia-Constain B., Strafella A.P. Cortical activity in Parkinson's disease during executive processing depends on striatal involvement. Brain 2007, 130(Pt 1):233-244.
29. Monsell S. Task switching. Trends Cogn. Sci. 2003, 7(3):134-140.
30. Muslimovic D., Post B., Speelman J.D., Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005, 65(8):1239-1245.
31. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9(1):97-113.
32. Owen A.M. Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry. Neuroscientist 2004, 10(6):525-537.
33. Palmer S.J., Ng B., Abugharbieh R., Eigenraam L., McKeown M.J. Motor reserve and novel area recruitment: amplitude and spatial characteristics of compensation in Parkinson's disease. Eur. J. Neurosci. 2009, 29(11):2187-2196.
34. Poewe W. Treatments for Parkinson disease - past achievements and current clinical needs. Neurology 2009, 72(Suppl. 7):S65-S73.
35. Poletti M., Emre M., Bonuccelli U. Mild cognitive impairment and cognitive reserve in Parkinson's disease. Parkinsonism Relat. Disord. 2011, 17(8):579-586.
36. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. A default mode of brain function. Proc. Natl. Acad. Sci. USA 2001, 98(2):676-682.
37. Raichle M.E., Snyder A.Z. A default mode of brain function: a brief history of an evolving idea. NeuroImage 2007, 37(4):1083-1090. (discussion 1097-1089).
38. Rottschy C., Kleiman A., Dogan I., Langner R., Mirzazade S., Kronenbuerger M., et al. Diminished activation of motor working-memory networks in Parkinson's disease. PLoS One 2013, 8(4):e61786.
39. Sahakian B.J., Owen A.M. Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J. R. Soc. Med. 1992, 85(7):399-402.
40. Schapira A.H., Olanow C.W. Drug selection and timing of initiation of treatment in early Parkinson's disease. Ann. Neurol. 2008, 64(Suppl. 2):S47-S55.
41. Smittenaar P., Chase H.W., Aarts E., Nusselein B., Bloem B.R., Cools R. Decomposing effects of dopaminergic medication in Parkinson's disease on probabilistic action selection - learning or performance?. Eur. J. Neurosci. 2012, 35(7):1144-1151.
42. Spitzer R.L., Williams J.B., Gibbon M., First M.B. The Structured Clinical Interview for DSM-III-R (SCID). I: history, rationale, and description. Arch. Gen. Psychiatry 1992, 49(8):624-629.
43. Stacy M., Bowron A., Guttman M., Hauser R., Hughes K., Larsen J.P., et al. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment. Mov. Disord. 2005, 20(6):726-733.
44. Vriend C., Raijmakers P., Veltman D.J., van Dijk K.D., van der Werf Y.D., Foncke E.M., et al. Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. J. Neurol. Neurosurg. Psychiatry 2013, 85(2):159-164.
45. Witt S.T., Stevens M.C. fMRI task parameters influence hemodynamic activity in regions implicated in mental set switching. NeuroImage 2013, 65:139-151.